Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Richmond, Virginia 23298


This multiple site, prospective, non-randomized study has been designed to compile information on the efficacy of the Contura™ MLB in delivering APBI in appropriately selected patients through evaluation of dosimetric success as compared with a single central lumen balloon device and through treatment outcomes.

Study summary:

Data collected during this study will include baseline patient demographics, information related to the time of implant, radiation therapy details, and removal of the device as well as recurrence data, cosmetic outcomes and toxicities. The patient's follow-up data will be collected during the patient's standard follow-up visits.


Inclusion Criteria: - Able and willing to sign informed consent - Age 50 or older at diagnosis - Life expectancy greater than 10 years (excluding diagnosis of breast cancer). - Surgical treatment of the breast must have been lumpectomy. The margins of the resected specimen must be histologically free of tumor (negative surgical margins per NSABP criteria). - On histologic examination, the tumor must be DCIS or invasive breast carcinoma. For patients with invasive breast cancer, an axillary staging procedure must be performed. Either: 1. sentinel node biopsy (SNB) alone if sentinel node(s) is/are negative; or 2. axillary dissection (minimum of six axillary nodes removed); and 3. the axillary node(s) must be pathologically negative. - The T stage must be Tis, T1, or T2. If T2, the tumor must be ≤ 3.0 cm in maximum diameter. - Estrogen receptor positive tumor Exclusion Criteria: - Age < 50 at diagnosis (regardless of histology) - Pregnant or breast-feeding (if appropriate, patient must use birth control during the study) - Active collagen-vascular disease - Paget's disease of the breast - History of DCIS or invasive breast cancer - Prior breast or thoracic RT for any condition - Multicentric carcinoma (DCIS or invasive) - Synchronous bilateral invasive or non-invasive breast cancer - Surgical margins that cannot be microscopically assessed or that are positive or close - Positive axillary node(s) - T stage of T2 with the tumor > 3 cm in maximum diameter or a T stage > 3 - Estrogen receptor negative tumor



Primary Contact:

Study Chair
Douglas W. Arthur, MD
Virginia Commonwealth University

Backup Contact:


Location Contact:

Richmond, Virginia 23298
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.